CO通过ISR诱导产生的应激颗粒对细胞衰老参与肺纤维化形成的干预机制研究
批准号:
82000074
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
陈颖卿
依托单位:
学科分类:
间质性肺疾病
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
陈颖卿
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
一氧化碳(CO)在细胞和组织损伤模型中具有抗炎症、抗氧化和抗凋亡作用。然而,CO是否具有抗衰老作用尚未阐明。前期研究发现,CO通过整合性应激反应(ISR)可诱导应激颗粒(SG)的形成,而SG可包裹Ⅰ型纤溶酶原激活物抑制因子(PAI-1);PAI-1在介导细胞衰老参与特发性肺纤维化发病的分子机制中起到关键作用。由此设想,CO诱导产生的SG可能通过包裹PAI-1减缓细胞衰老,从而抑制肺纤维化的形成。本研究用依托泊苷和细胞传代培养方法分别建立DNA损伤和复制性衰老模型;用ISR抑制剂、免疫荧光染色和免疫共沉淀法,探讨CO诱导产生的SG是否通过包裹PAI-1减缓细胞衰老;用依托泊苷或博莱霉素建立特发性肺纤维化模型,探讨CO是否通过产生SG抑制肺纤维化的形成。本研究将首次揭示CO通过ISR诱导产生的SG对细胞衰老参与肺纤维化形成的干预机制,为利用外源性CO预防与治疗特发性肺纤维化提供实验依据。
英文摘要
Carbon monoxide (CO) possesses anti-inflammatory, anti-oxidant and anti-apoptotic properties in a variety of cellular- and tissue-injury models. However, whether CO exerts anti-senescence effects is not well defined. Our recent study showed that CO can induce stress granule (SG) formation through integrated stress response (ISR). Additionally, SG can sequestrate plasminogen activator inhibitor-1 (PAI-1), which exhibits an essential role in the cellular senescence-mediated pulmonary fibrosis. Based on these reports, we hypothesized that CO-induced SG might suppress cellular senescence and pulmonary fibrosis via sequestration of PAI-1. Human diploid lung fibroblasts and type II alveolar epithelial cells were applied to establish DNA damage and replicative cellular senescence. ISR inhibitor was used to identify whether CO-induced SG formation can delay the cellular senescence through PAI-1 sequestration. Next, to verify whether SG assembly is involved in prevention of pulmonary fibrosis, we constructed idiopathic pulmonary fibrosis model by oropharyngeal instillation of etoposide and bleomycin. This study is the first one to demonstrate that CO can inhibit cellular senescence and pulmonary fibrosis via induction of SG assembly, and which provides important experimental and clinical application prospects on treatment of idiopathic pulmonary fibrosis.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.7501/j.issn.0253-2670.2021.20.013
发表时间:2021
期刊:中草药
影响因子:--
作者:曹瑀莹;杜丙秀;李劭恒;袁硕;陶雅军;刘丽萍;陈颖卿
通讯作者:陈颖卿
DOI:--
发表时间:2021
期刊:Biomedicine & Pharmacotherapy
影响因子:--
作者:Yingqing Chen;Xiaomin Shao;Xiangge Zhao;Yuan Ji;Xiaorong Liu;Peixuan Li;Mingyu Zhang;Qianqian Wang
通讯作者:Qianqian Wang
DOI:10.7501/j.issn.0253-2670.2022.09.034
发表时间:2022
期刊:中草药
影响因子:--
作者:白羽;李傲寒;刘丽萍;陈颖卿
通讯作者:陈颖卿
DOI:10.1155/2021/9926284
发表时间:2021
期刊:Oxidative medicine and cellular longevity
影响因子:--
作者:Chen Y;Jiang F;Kong G;Yuan S;Cao Y;Zhang Q;Wang Q;Liu L
通讯作者:Liu L
DOI:10.1016/j.jcyt.2022.12.004
发表时间:2023
期刊:Cytotherapy
影响因子:--
作者:You Li;Qi Wang;Jiaxin Li;Aohan Li;Qianqian Wang;Qinggao Zhang;Yingqing Chen
通讯作者:Yingqing Chen
国内基金
海外基金















{{item.name}}会员


